Related Experiment Video

Updated: May 28, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
08:12

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets

Published on: September 6, 2019

Evolution of hypogammaglobulinemia in premature and full-term infants

Giampaolo Ricci1, V Piccinno, A Giannetti

  • 1Department of Pediatrics, University of Bologna, Italy. giampaolo.ricci@unibo.it

International Journal of Immunopathology and Pharmacology
|October 8, 2011
PubMed

Insights

Infant hypogammaglobulinemia, a condition of low immunoglobulin levels, typically resolves in premature infants by 7.2 months. Full-term infants show varied recovery timelines, highlighting differences in immune system maturation.

Area of Science:

  • Pediatrics
  • Immunology
  • Neonatology

Background:

  • Limited data exists on the longitudinal course of hypogammaglobulinemia in infants.
  • Understanding immune system development is crucial for infant health outcomes.
  • Hypogammaglobulinemia can affect infants, necessitating studies on its natural history.

Purpose of the Study:

  • To investigate the clinical and immunological progression of hypogammaglobulinemia in premature and full-term infants.
  • To determine the age of immunoglobulin (Ig) normalization in these infant populations.
  • To characterize different patterns of recovery from hypogammaglobulinemia.

Main Methods:

  • A cohort of 24 infants (0-36 months) diagnosed with hypogammaglobulinemia was studied.
  • Participants included 11 premature and 13 full-term infants.
  • Serum levels of IgG, IgA, and IgM were monitored to assess immunoglobulin recovery.

Main Results:

  • Premature infants showed IgG normalization at a mean age of 7.2 months.
  • Full-term infants exhibited diverse recovery patterns, categorized by normalization within 12, 36, or after 36 months.
  • Isolated IgG reduction was most common (62.5%), followed by combined IgG/IgA (29.2%) and IgG/IgM (8.3%) deficiencies.

Conclusions:

  • All premature infants in the study achieved immune recovery, albeit with levels at the lower end of normal ranges initially.
  • Transient hypogammaglobulinemia in full-term infants demonstrates varied recovery timelines.
  • The study underscores distinct immunological maturation trajectories between premature and full-term infants regarding immunoglobulin levels.

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...